Feedback / Questions
Jiataile (sacituzumab tirumotecan) - Merck (MSD)
tagitanlimab (HBM9167) - Harbour BioMed
EP0031 - Ellipses Pharma
https://www.prnewswire.com/news-releases/kelun-biotech-to-present-results-of-six-clinical-studies-at-2025-asco-annual-meeting-302436869.html
Apr 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next